Cowen Healthcare Investments
17 portfolio companies · 4 on the map · $744.3M raised · 4 cities
Portfolio map
4 Cowen Healthcare Investments portfolio companies on the map.
Portfolio companies

Keros Therapeutics
Lexington
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Biotechnology Research$379.5MEst. 2016
DELFI Diagnostics
Palo Alto
Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.
Medical and Diagnostic Laboratories$364.8MEst. 2019KSQ Therapeutics
lexington
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Pharmaceutical ManufacturingSeries CEst. 2015
Lycia Therapeutics
South San Francisco
Lycia is a Series B biotech company built on a platform developed by academic founder Professor Carolyn Bertozzi at Stanford, arising from Stanford research, with potential to deliver next-generation therapeutics for difficult-to-treat dise
BiotechnologySeries CEst. 2020
More portfolio companies
13 more Cowen Healthcare Investments investments we track beyond the map.
Aro BiotherapeuticsPhiladelphia · Series B
Nuvig TherapeuticsRedwood City · Series B
AnaveonBottmingen · Series B
Repare TherapeuticsSaint Laurent · Series B
Evox TherapeuticsOxford · Series C
Neuron23San Francisco · Series C
ACELYRINLos Angeles · Series C
F2GManchester · Private Equity
Semma TherapeuticsCambridge · Series B
Pliant TherapeuticsSouth San Francisco · Series C
Ikena OncologyBoston · Series B
Escient PharmaceuticalsSan Diego · Series C
Aeglea BioTherapeuticsAustin · Series B
Portfolio map
4 Cowen Healthcare Investments portfolio companies on the map.